OraSure Technologies June 15th Short Interest Update

OraSure Technologies (NASDAQ:OSUR) stated gains of 3,971 shares or 0.2% in the short interest. The short interest registered from 2,639,023 on May 31,2016 to 2,642,994 on June 15,2016. In terms of floated shares, the shorted positions stood at 4.9%. The stock has been averaging 602,347 shares daily in trading and would need 4 days to cover the shorts. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.

OraSure Technologies (NASDAQ:OSUR): The stock opened at $6.57 on Friday but the bulls could not build on the opening and the stock topped out at $6.74 for the day. The stock traded down to $6.44 during the day, due to lack of any buying support eventually closed down at $6.61 with a loss of -2.94% for the day. The stock had closed at $6.81 on the previous day. The total traded volume was 2,183,335 shares.

The company shares have rallied 22.18% from its 1 Year high price. On Jun 6, 2016, the shares registered one year high at $7.99 and the one year low was seen on Sep 30, 2015. The 50-Day Moving Average price is $7.14 and the 200 Day Moving Average price is recorded at $6.73.

OraSure Technologies (NASDAQ:OSUR) has tumbled 4.76% during the past week and has dropped 11.98% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 3.17%. OraSure Technologies (NASDAQ:OSUR) has underperformed the index by 9.32% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.